Jyotsna Singh
India’s newly amended patent rules threaten affordable medicines in the Global South

New amendments to patent rules in India will jeopardize the country’s ability to produce generics, dealing a strong blow to access to medicines in both India and other countries of the Global South

Pandemic Treaty continues to negate principles of equity and justice

Pandemic Treaty talks face hurdles as equity concerns, corporate dominance, and calls for fair health frameworks remain unaddressed

Sí, podemos impedir que las patentes obstaculicen el tratamiento de la tuberculosis

Un día antes del Día Mundial de la Tuberculosis, la Oficina de Patentes de la India rechazó la solicitud del gigante farmacéutico Jannsen de prorrogar la patente del medicamento bedaquilina.

World TB Day drug patent Yes, we can stop patents getting in the way of TB treatment

A day ahead of World TB Day, the Indian Patent Office rejected pharma giant Jannsen’s application for a patent extension on drug bedaquiline. If the patent had been extended, public and family budgets would have remained burdened by unjustifiably high costs of the drug

Health movement in South Korea fights for universal access to medicines

Civil society in South Korea renewed its commitment to ensure universal access to medicines and public pharmaceutical production, building on decades of mobilization

Cuban Vaccine to be produced in Italy in attempt to solve WHO prequalification hurdle

Cuba–Italy collaboration on COVID-19 moves forward as memorandum for production of vaccines is signed between Finlay Institute of Vaccines and Italian biotech company

Cuba is helping vaccinate the world

Only 9.5% of people in low-income countries have received a single dose of the vaccine. Cuba has a comprehensive plan to support vaccine distribution in the global south to make sure none are left behind

The people of the world vs Pfizer Inc.

During the Covid-19 pandemic, Pfizer has used every opportunity to maximize its profits, even if this meant reduced access to life-saving medical products for most of the world. The same is about to happen in the case of Paxlovid, the company’s Covid-19 oral treatment

The many faces of travel bans

After the discovery of omicron, several rich countries blocked air traffic to southern Africa, stalling the delivery of supplies needed for the pandemic response and showing their racist bias towards the Global South

Vaccine inequity persists as African continent yet to surpass 10% vaccination rate

While the world is discussing ways to move on from the pandemic and return to normalcy, an entire continent is struggling to get even the first dose of vaccine, with little concern expressed by international bodies

Cuba-Vietnam: On the road to vaccine self-reliance

Cuba and Vietnam share a rich history of anti-imperialist struggles and are living examples of the daily battle against US hegemony. During the pandemic, they are paving the way for South-South solidarity and enhancing local production, a must for a self-reliant Global South

Inequity in COVID-19 testing has far reaching consequences for poor countries

Testing is crucial to combat the pandemic. But with all the funds and attention going towards vaccines, diagnostics is suffering, impeding key steps to curb the spread of the virus